Centene Corporation
CNCHealthcareNASDAQHealthcare Plans · Last scanned Sep 8, 2026
Scan Results
Daily timeframeCentene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. The $33.12B market capitalization puts CNC squarely in large-cap range for its industry. It operates through four segments: Medicaid, Medicare, Commercial, and Other.
Market Cap
$33.12B
Beta
1.11
P/E (TTM)
—
P/E (Fwd)
12.62
EPS (TTM)
$-10.36
EPS (Fwd)
$5.31
ROE
-20.4%
ROA
2.5%
Cash
$27.06B
Total Debt
$16.10B
Free CF
$9.64B
52W Change
115.8%
Annual Financials
Cash vs Debt
Where CNC stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, CNC finished 27.08% above its 150-day moving average ($52.99) and 34.60% above its 200-day moving average ($50.03). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CNC overbought or oversold?
At the September 3, 2026 close, CNC's RSI(14) was 55.0, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The balance sheet looks solid with $27.06B in cash comfortably exceeding the $16.10B debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Annual free cash flow of $9.64B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of -20.4% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 2.5% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $144.55B (2022) to $194.78B (2025), reflecting a 35% increase over the period.
As with any equity investment, CNC carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. No single metric tells the full story. Reviewing CNC's risk profile alongside its fundamentals and technical indicators provides a more complete picture.